Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 20 peer-reviewed journal articles Updated
Clinical genetics

Living with a Rare or Undiagnosed Condition

At a Glance

When hypergonadotropic hypogonadism and cataracts remain unexplained, care can still focus on symptoms, regular monitoring of hearing, neurologic, metabolic, kidney, and heart health, urgent warning signs, psychological support, and rare-disease resources.

Living with a combination of hypergonadotropic hypogonadism and cataracts often places families on what doctors call the diagnostic odyssey. This is the period of time—sometimes lasting years—between the first appearance of symptoms and the discovery of a specific genetic cause [1][2].

While not having a single “name” for a condition can be frustrating and isolating, it is important to remember that you can still receive excellent medical care by managing the symptoms you do see while the genetic search continues [3][4].

The Psychological Toll of the “Odyssey”

The uncertainty of a rare or undiagnosed condition is not just a medical challenge; it is a mental health challenge. Research shows that families facing diagnostic delays can experience:

  • Persistent Anxiety and Frustration: Many people with rare conditions report feeling worried or low because of the unknown [1].
  • Caregiver Overload: Caregivers for those with ultra-rare diseases often report feeling “overloaded” by the physical and emotional demands of navigating multiple health systems [2].
  • The “Expert” Burden: Parents often find themselves becoming the “coordinator” and “expert” on their child’s condition, which can be exhausting [5].

If you feel overwhelmed, irritable, or have difficulty concentrating, these are common reactions to the stress of the odyssey. Seeking psychological support or joining a patient advocacy group can help reduce this isolation [1][6].

Systemic Monitoring: Beyond Eyes and Hormones

Because this combination of symptoms often suggests a “multisystem” syndrome, your team may monitor other parts of your body even if they seem healthy now [7]. Depending on your specific suspected diagnosis, this may include:

  • Hearing Health: Some conditions, like Wolfram spectrum or Perrault syndrome, involve progressive hearing loss that may not be obvious at first [8][9].
  • Neurological Signs: Doctors will watch for changes in balance (ataxia), muscle weakness, or “floppiness” (hypotonia) [10][11].
  • Metabolic Health: Regular checks of blood glucose (sugar) and lipids (fats) may be needed, as some rare syndromes increase the risk of early-onset diabetes [8][12].
  • Kidney and Heart Function: In rare cases, syndromes like Bardet-Biedl require monitoring of kidney health and heart rhythms, if suspected [13][14].

When to Seek Urgent Medical Attention

Knowing what is a “red flag” versus a routine symptom can help lower daily stress.

Seek Urgent Care/Call Doctor If: Routine: Discuss at Next Visit
Sudden Vision Changes: A new “curtain” over vision, sudden severe pain, extreme redness, or discharge in an eye that had surgery [15]. Slowly worsening vision or a need for a new glasses prescription.
New Neurological Symptoms: Sudden difficulty walking, frequent falls, or new seizure activity [16]. Mild, stable issues with coordination or muscle tone.
Metabolic Emergencies: Extreme thirst, frequent urination, and unexplained weight loss with vomiting or deep breathing (signs of high blood sugar/DKA) [8]. Standard monitoring of growth and hormone levels.
Cardiac/Fainting: Sudden fainting, chest pain, or a racing heart (palpitations) [14]. Routine physical exams and blood pressure checks.

Building a Support Network

You do not have to navigate this journey alone. Advocacy organizations like the National Organization for Rare Disorders (NORD) or clinical research networks like the Undiagnosed Diseases Network (UDN) provide resources and evaluations for families who are still searching for answers [17][18]. These groups can offer peer mentoring and practical advice on how to manage school, work, and insurance while living with a rare condition [19].

Focusing on quality of life—ensuring that medical appointments do not replace all of life’s joys—is a vital part of the treatment plan [20].

Common questions in this guide

How can we cope while the cause of the condition is still unknown?
A specific diagnosis may take time, but care can continue by treating and monitoring the symptoms that are already present. Psychological support, a social worker, peer groups, and a trusted care coordinator can reduce isolation and help with practical demands.
What health problems should be checked besides cataracts and hormone levels?
Depending on the suspected genetic condition, clinicians may check hearing, balance, muscle strength, blood sugar, blood fats, kidney function, and heart rhythm. Monitoring is individualized because not every person will develop all of these problems.
When do vision or other symptoms need urgent medical attention?
Seek prompt care for a sudden curtain or major change in vision, severe eye pain, marked redness, or discharge after eye surgery. New trouble walking, repeated falls, seizures, extreme thirst with frequent urination and vomiting, deep breathing, fainting, chest pain, or a racing heartbeat also need urgent medical attention.
Can genetic test results be reviewed again if no diagnosis is found?
Yes, ask the genetics team whether previously collected data can be reanalyzed as scientific knowledge and gene-disease links change. The timing of a review depends on the tests performed and the family’s situation.
How can we coordinate care across multiple specialists?
Keep a shared care map with diagnoses under consideration, test results, medications, appointments, and each clinician’s role. Ask the team to identify a point person and a reliable way for specialists to communicate with one another.
Where can families find support during a rare-disease search?
The National Organization for Rare Disorders and the Undiagnosed Diseases Network may offer information, evaluations, research connections, and practical resources. Local advocacy groups and peer mentors can also help with school, work, insurance, and the emotional strain of uncertainty.
What signs mean someone may need mental health support?
Persistent anxiety, low mood, irritability, feeling overloaded, or trouble concentrating can be signs that extra support would help. A clinician, psychologist, or social worker can discuss counseling and other resources for the patient or caregiver.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Given that we are still in the 'diagnostic odyssey,' what symptoms should we be monitoring for that aren't related to the eyes or hormones?
  2. 2.Can you help us create a 'Care Map' that lists all our specialists and how they should communicate with each other?
  3. 3.Is there a specific rare disease patient advocacy group or registry you recommend for our family?
  4. 4.How often should we revisit our genetic testing data to see if new discoveries can provide a name for this condition?
  5. 5.What are the signs that I (or my child) might need professional psychological support or a referral to a social worker?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (20)
  1. 1

    Psychosocial impact at the time of a rare disease diagnosis.

    Benito-Lozano J, Arias-Merino G, Gómez-Martínez M, et al.

    PloS one 2023; (18(7)):e0288875 doi:10.1371/journal.pone.0288875.

    PMID: 37506095
  2. 2

    Ultra-rare ultra-care: Assessing the impact of caring for children with ultra rare diseases.

    Domaradzki J, Walkowiak D

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2024; (48()):78-84 doi:10.1016/j.ejpn.2023.12.003.

    PMID: 38071849
  3. 3

    Living with a rare disease - experiences and needs in pediatric patients and their parents.

    Witt S, Schuett K, Wiegand-Grefe S, et al.

    Orphanet journal of rare diseases 2023; (18(1)):242 doi:10.1186/s13023-023-02837-9.

    PMID: 37568186
  4. 4

    Participation in a national diagnostic research study: assessing the patient experience.

    Rosenfeld LE, LeBlanc K, Nagy A, et al.

    Orphanet journal of rare diseases 2023; (18(1)):73 doi:10.1186/s13023-023-02695-5.

    PMID: 37032333
  5. 5

    The diagnostic odyssey: insights from parents of children living with an undiagnosed condition.

    Bauskis A, Strange C, Molster C, Fisher C

    Orphanet journal of rare diseases 2022; (17(1)):233 doi:10.1186/s13023-022-02358-x.

    PMID: 35717227
  6. 6

    Addressing psychosocial vulnerability in rare diseases: a call to action from a European expert consensus study.

    Smits RM, Aerts A, Angelov T, et al.

    Orphanet journal of rare diseases 2025; (20(1)):543 doi:10.1186/s13023-025-04017-3.

    PMID: 41146214
  7. 7

    Congenital cataract: a guide to genetic and clinical management.

    Bell SJ, Oluonye N, Harding P, Moosajee M

    Therapeutic advances in rare disease 2020; (1()):2633004020938061 doi:10.1177/2633004020938061.

    PMID: 37180497
  8. 8

    Dominant ER Stress-Inducing WFS1 Mutations Underlie a Genetic Syndrome of Neonatal/Infancy-Onset Diabetes, Congenital Sensorineural Deafness, and Congenital Cataracts.

    De Franco E, Flanagan SE, Yagi T, et al.

    Diabetes 2017; (66(7)):2044-2053 doi:10.2337/db16-1296.

    PMID: 28468959
  9. 9

    Perrault syndrome with amenorrhea, infertility, Tarlov cyst, and degenerative disc.

    Al-Jaroudi D, Enabi S, AlThagafi MS

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 2019; (35(12)):1037-1039 doi:10.1080/09513590.2019.1637407.

    PMID: 31274036
  10. 10

    Genotype-phenotype correlations in ocular manifestations of Marinesco-Sjögren syndrome: Case report and literature review.

    Bayram N, Kaçar Bayram A, Daimagüler HS, et al.

    European journal of ophthalmology 2022; (32(3)):NP92-NP97 doi:10.1177/11206721211021291.

    PMID: 34075802
  11. 11

    Clinical Reasoning: Clinical Manifestations and Diagnostic Challenges in a 16-Year-Old With Early-Onset Ataxia.

    Chadha D, Viswanathan LG, Santhoshkumar R, et al.

    Neurology 2025; (104(2)):e210253 doi:10.1212/WNL.0000000000210253.

    PMID: 39729613
  12. 12

    Endocrine abnormalities in ataxia telangiectasia: findings from a national cohort.

    Nissenkorn A, Levy-Shraga Y, Banet-Levi Y, et al.

    Pediatric research 2016; (79(6)):889-94 doi:10.1038/pr.2016.19.

    PMID: 26891003
  13. 13

    Bardet-Biedl syndrome presenting with early-onset infantile obesity.

    Akhila P, Naik J, Arun Babu T

    BMJ case reports 2026; (19(1)) doi:10.1136/bcr-2025-268160.

    PMID: 41611321
  14. 14

    Perioperative management of patients with genetic multisystem diseases associated with pre‑excitation.

    Staikou C, Stamelos M, Stavroulakis E

    Anaesthesiology intensive therapy 2019; (51(2)):133-146 doi:10.5114/ait.2019.86278.

    PMID: 31268275
  15. 15

    Evaluating the evidence for and against the use of IOLs in infants and young children.

    Kumar P, Lambert SR

    Expert review of medical devices 2016; (13(4)):381-9 doi:10.1586/17434440.2016.1153967.

    PMID: 26878234
  16. 16

    BRCC3 -Associated Syndromic Moyamoya Angiopathy Diagnosed Through Clinical RNA Sequencing.

    Venema M, Albuainain F, Schot R, et al.

    Clinical genetics 2025; (107(3)):341-347 doi:10.1111/cge.14650.

    PMID: 39552268
  17. 17

    Utilization of telehealth in paediatric genome-wide sequencing: Health services implementation issues in the CAUSES Study.

    Elliott AM, Dragojlovic N, Campbell T, et al.

    Journal of telemedicine and telecare 2023; (29(4)):318-327 doi:10.1177/1357633X20982737.

    PMID: 33470133
  18. 18

    I've Never Heard of This! An Approach to Child and Family-Centred Care for Children and Young People With Rare Diseases.

    Ewans LJ, Pierce K, Farley E, et al.

    Journal of paediatrics and child health 2025; doi:10.1111/jpc.70267.

    PMID: 41431132
  19. 19

    "We are ambassadors, we are advocates": rare disease patient advocacy groups as knowledge brokers across health and social systems-a qualitative study from Poland.

    Domaradzki J

    Frontiers in public health 2026; (14()):1743598 doi:10.3389/fpubh.2026.1743598.

    PMID: 41835439
  20. 20

    19q12q13.2 duplication syndrome: neuropsychiatric long-term follow-up of a new case and literature update.

    Nacinovich R, Villa N, Broggi F, et al.

    Neuropsychiatric disease and treatment 2017; (13()):2545-2550 doi:10.2147/NDT.S142356.

    PMID: 29042784

This page is for educational purposes and does not constitute medical advice. Monitoring and urgent warning signs vary by person, so discuss your symptoms and follow-up plan with your genetics, hormone, and eye-care teams.

Get notified when new evidence is published on Hypergonadotropic hypogonadism-cataract syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.